Cargando…
Effect of carbocisteine on patients with COPD: a systematic review and meta-analysis
BACKGROUND: COPD is the fourth leading cause of death in the world. It is a common, progressive, treatable and preventable disease. The exacerbation of COPD is associated with the peripheral muscle force, forced expiratory volume in 1 second (FEV(1)), the quality of life and mortality. Many studies...
Autores principales: | Zeng, Zheng, Yang, Dan, Huang, Xiaoling, Xiao, Zhenliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546781/ https://www.ncbi.nlm.nih.gov/pubmed/28814855 http://dx.doi.org/10.2147/COPD.S140603 |
Ejemplares similares
-
Carbocisteine inhibits the expression of Muc5b in COPD mouse model
por: Song, Yan, et al.
Publicado: (2019) -
The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease
por: Hooper, C, et al.
Publicado: (2008) -
Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application
por: Dhanure, Shivanand, et al.
Publicado: (2014) -
L-carbocisteine can cause cholestasis with vanishing bile duct syndrome in children: A case report
por: Takaki, Yugo, et al.
Publicado: (2022) -
Effectiveness of meditative movement on COPD: a systematic review and meta-analysis
por: Wu, Lu-Ling, et al.
Publicado: (2018)